M. Pashenkov et al., Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis, SC J IMMUN, 50(3), 1999, pp. 302-308
Interleukin-15 (IL-15) is a novel IL-2-like cytokine expressed by cells of
the monocyte/macrophage and epithelial lineages. Cytokines might be involve
d in the pathogenesis of multiple sclerosis (MS). Using immunocytochemistry
, we analysed spontaneous expression of IL-15 by peripheral blood (PB) and
cerebrospinal fluid (CSF) mononuclear cells (MNC) from patients with MS, ot
her neurological diseases (OND) and healthy controls. IL-15- positive perip
heral blood mononuclear cells (PBMNC) were elevated in patients with MS com
pared to healthy controls (P<0.05). The elevation of IL-15- positive PBMNC
was restricted to patients with chronic progressive MS and not observed in
patients studied during the relapsing-remitting phase of MS. The numbers of
IL-15- expressing PBMNC correlated with the duration and disability of MS
(r = 0.45. P < 0.001, and r = 0.39, P < 0.01, respectively). IL-15 was unde
tectable in CSF MNC, and ELISA showed low CSF levels of IL-15 in occasional
patients with MS and OND. IL-15 is a potent growth factor for gamma delta
T cells, but then was no correlation between IL-15 expression by PBMNC and
percentage of gamma delta T cells in blood from the MS patients. Together,
these data demonstrate that IL-15 expression by PBPMNC is upregulated in th
e chronic stage of MS.